FDAnews
www.fdanews.com/articles/142803-more-hepatitis-c-developments-driving-home

More Hepatitis C Developments Driving Home

January 2, 2012
Peregrine Pharmaceuticals is a year-end winner in small-cap biotech and emerging pharma based upon hepatitis-C Phase II trial data. The preliminary data shows that antiviral activity and a positive safety profile at both bavituximab doses were evaluated.
24/7 Wall St.